SCHEMBL7571276

SCHEMBL7571276

Cc1cccc(-c2cc(C=O)ccc2C#N)c1C

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.37
AR P10275 4/20 0.37
ALDH1A1 P00352 6/20 0.33
KDM4E B2RXH2 2/20 0.33
GAA P10253 2/20 0.33
GALR3 O60755 1/20 0.33
HPGD P15428 1/20 0.33
USP8 P40818 2/20 0.32
ALDH1A3 P47895 1/20 0.32
USP7 Q93009 1/20 0.32
KDM1A O60341 1/20 0.32
CYP2A6 P11509 1/20 0.32
NISCH Q9Y2I1 1/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
KMT2A Q03164 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7570617 0.88 AR (0.44) TSHRARALDH1A1KDM4EGAA
SCHEMBL24027812 0.85 TSHR (0.39) TSHRARALDH1A1KDM4EGAA
SCHEMBL7569312 0.78 CYP2A6 (0.40) ARALDH1A1KDM4EHPGDUSP8
SCHEMBL7575302 0.77 AR (0.38) ARALDH1A1KDM4EGAAGALR3
SCHEMBL7569318 0.77 AR (0.47) ARALDH1A1KDM4EGAAGALR3
SCHEMBL7576912 0.77 MCL1 (0.47) ALDH1A1KDM4E
SCHEMBL7575998 0.76 KDM4E (0.38) ALDH1A1KDM4EGAAHPGDALDH1A3
SCHEMBL7577589 0.76 KDM4E (0.43) ARALDH1A1KDM4EGAAGALR3
SCHEMBL1795902 0.76 TSHR (0.43) TSHRARALDH1A1KDM4EHPGD
SCHEMBL7571007 0.75 USP8 (0.37) ARALDH1A1KDM4EGAAGALR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020019527-A1 Substituted phenyl farnesyltransferase inhibitors ABBOTT LABORATORIES 2002-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019527-A1 Substituted phenyl farnesyltransferase inhibitors FNTA, FNTB, SLC10A1 TSHR 3465/4885AR 4525/4885ALDH1A1 385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.